/
DNA.Fund is a DeFi collective focused on integrating blockchain technology with genomics to enhance personalized medicine, genetic research, and data sovereignty. It emphasizes secure funding and democratized investment in scientific advancements, envisioning a future where genetic data is privately stored and controlled by individuals. DNA.Fund provides tools for blockchain-genomics integration, aiming to revolutionize healthcare through personalized solutions. The DNA cryptocurrency, launched in 2025 on Solana, supports this vision and is a key player in the web3 ecosystem. DNA acts as a conduit for investment and consultation in blockchain innovations, managed from Santa Monica, New York, and San Juan, fostering a vibrant community for digital economy transformation. Despite its 2025 launch, DNA originated in 2017 under crypto pioneers Brock Pierce and Scott Walker, advising over 100 decentralized projects. It remains significant in promoting blockchain’s role in genomic research advancements.
DNA.Fund is a DeFi collective focused on integrating blockchain technology with genomics to enhance personalized medicine, genetic research, and data sovereignty. It emphasizes secure funding and democratized investment in scientific advancements, envisioning a future where genetic data is privately stored and controlled by individuals. DNA.Fund provides tools for blockchain-genomics integration, aiming to revolutionize healthcare through personalized solutions. The DNA cryptocurrency, launched in 2025 on Solana, supports this vision and is a key player in the web3 ecosystem. DNA acts as a conduit for investment and consultation in blockchain innovations, managed from Santa Monica, New York, and San Juan, fostering a vibrant community for digital economy transformation. Despite its 2025 launch, DNA originated in 2017 under crypto pioneers Brock Pierce and Scott Walker, advising over 100 decentralized projects. It remains significant in promoting blockchain’s role in genomic research advancements.
DNA.Fund is a decentralized finance (DeFi) collective that focuses on funding projects at the intersection of blockchain technology and genomics. It aims to leverage blockchain and genetic data to advance personalized medicine, genetic research, and individual data sovereignty. The platform emphasizes secure, transparent funding and democratized investments to foster scientific innovation.
DNA.Fund integrates blockchain with genomics by providing tools and frameworks to support research and development in the field, promoting secure storage and privacy of genetic data. This integration aims to allow individuals to control access to their genetic information and enable blockchain projects to ethically and compliantly utilize genomics data.
DNA.Fund benefits the genomics and blockchain industries by enabling personalized medicine advancements, accelerating medical breakthroughs, and maintaining individual data sovereignty. By combining blockchain technology with genomics, the platform ensures secure storage of sensitive data and fosters innovations that can tailor healthcare solutions to individual genetic profiles.
DNA.Fund distinguishes itself from other DeFi projects by focusing specifically on the intersection of blockchain and genomics. Unlike traditional DeFi projects that focus on financial transactions and assets, DNA.Fund emphasizes enhancing personalized medicine and genetic research through secure, blockchain-based funding mechanisms, setting it apart as an innovator in both the blockchain and healthcare sectors.
DNA (DNA) token's price volatility arises from its launch on the Solana platform and the current trading of its extensive supply of 42 quadrillion tokens within a volatile market. Despite no tokens being in circulation yet, its 24-hour trading volume variation highlights investor speculation and reactions to its novel intersection with genomics that may influence price fluctuations.
DNA holds historical significance in the crypto industry as a firm founded by Brock Pierce and Scott Walker, who were instrumental in early cryptocurrency developments, including the world's first ICO and first security token. DNA operates as an investment and consulting firm, contributing to over 100 decentralized ecosystem launches, making a substantial impact on the industry's growth.
dna 2.0 operates in the solana ecosystem, offering a vast supply of tokens with an emphasis on scalability and efficiency, trading actively in the market.
DNA AI operates on the Solana blockchain with a massive token supply and enables trading in the DeFi space, reflecting key web3 functionalities.
DNA Token is a secure ERC20 on World Chain, fostering growth via unique rewards and human verification.
DNA PEPE is a Solana-based cryptocurrency with a vast supply, offering decentralized trading within the Web3 space.
SQUIDGAME DNA is a 2024-launched cryptocurrency on Solana with decentralized transaction facilitation.
Genomes.io: A blockchain platform for secure genomic data storage & management, enabling privacy, data sharing with consent, and monetization opportunities for users.
Encrypgen's Gene-Chain leverages blockchain for secure genomic data storage, sharing, and monetization, ensuring user privacy and control.
GenoBank.io offers a privacy-centric DNA/RNA kit using blockchain for secure genetic data storage, sharing, and management, ensuring user control and data integrity.
PEPE DNA is a cryptocurrency on Solana launched in 2024 with a massive token supply, currently experiencing price volatility and market interest.
bioDAOs utilizes blockchain on Solana to boost transparency and collaboration in biomedicine, with its BIO token driving governance and resource distribution.
Bio.xyz, a DAO at blockchain and biotech nexus, democratizes biotech research via decentralized funding, data sharing, and community-driven collaborations on Ethereum.
Supernova Fund is a digital VC targeting early-stage DeFi, NFT, and Web3 projects. Combining DAO governance with traditional structures, it offers a community-driven investment approach to boost blockchain ecosystem development.
